Innovate Biopharmaceuticals (INNT) Competitors

Innovate Biopharmaceuticals (NASDAQ:INNT) and Vaxxinity (NASDAQ:VAXX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, community ranking, media sentiment and institutional ownership.

Does the media refer more to INNT or VAXX?

In the previous week, Innovate Biopharmaceuticals' average media sentiment score of 0.00 equaled Vaxxinity'saverage media sentiment score.

Company	Overall Sentiment
Innovate Biopharmaceuticals	Neutral
Vaxxinity	Neutral

Which has better earnings & valuation, INNT or VAXX?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innovate Biopharmaceuticals	N/A	N/A	-$27.05M	N/A	N/A
Vaxxinity	N/A	N/A	-$56.93M	-$0.45	0.00

Do insiders and institutionals hold more shares of INNT or VAXX?

5.9% of Innovate Biopharmaceuticals shares are owned by institutional investors. Comparatively, 82.9% of Vaxxinity shares are owned by institutional investors. 7.9% of Innovate Biopharmaceuticals shares are owned by insiders. Comparatively, 64.1% of Vaxxinity shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community prefer INNT or VAXX?

Innovate Biopharmaceuticals received 198 more outperform votes than Vaxxinity when rated by MarketBeat users. Likewise, 65.48% of users gave Innovate Biopharmaceuticals an outperform vote while only 38.46% of users gave Vaxxinity an outperform vote.

Company	Underperform	Outperform
Innovate Biopharmaceuticals	Outperform Votes 203 65.48%	Underperform Votes 107 34.52%
Vaxxinity	Outperform Votes 5 38.46%	Underperform Votes 8 61.54%

Is INNT or VAXX more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Innovate Biopharmaceuticals	N/A	N/A	-234.42%
Vaxxinity	N/A	N/A	N/A

Which has more risk & volatility, INNT or VAXX?

Innovate Biopharmaceuticals has a beta of -0.39, meaning that its stock price is 139% less volatile than the S&P 500. Comparatively, Vaxxinity has a beta of -17.57, meaning that its stock price is 1,857% less volatile than the S&P 500.

Summary

Innovate Biopharmaceuticals and Vaxxinity tied by winning 4 of the 8 factors compared between the two stocks.